Small and large companies No. 1: Central Bank Central Bank President and CEO Robert Mrlik says the key to keeping employees for a long time is ensuring that decisions about their future don’t take an ...
The difference in prices for U.S. shale oil in West Texas and at Houston has widened in the last two months on dwindling ...
Occidental is teaming up with another major Houston-based energy company for a project near the Houston Ship Channel.
HOUSTON (AP) — HOUSTON (AP) — Plains All American Pipeline L.P. (PAA) on Friday reported third-quarter earnings of $220 million. On a per-share basis, the Houston-based company said it had profit of ...
This trend is only expected to begin reversing in 2028, when Yardi Matrix estimates that the United States will see 404,559 new multifamily units. And in 2029, Yardi Matrix predicts that 426,485 new ...
More companies outside Houston are looking at new drug development models built here, one life sciences CEO says.
A federal appeals court will hear arguments Dec. 10 over the future of a proposed pipeline supplying the planned Cumberland Gas Plant in Stewart County.
Plains Still Lacks of Pricing Power Due to Oversupply of Crude Oil Long-Haul Pipeline Infrastructure
Plains signed contracts for its Permian long-haul pipeline portfolio that extended the duration ... is less valuable in this environment where more barrels are moving to the Houston complex for export ...
Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported third-quarter 2024 results. Third-Quarter Results Reported net income attributable to PAA of $220 ...
Canadian-government owned oil pipeline operator Trans Mountain on Friday said it will shut the Puget Sound Pipeline from Laurel to Anacortes, Washington, for about seven days in mid-November to ...
A controversial pipeline project is seeking regulatory approval to shorten ... PRGT, co-owned by the Nisga’a and Houston-based Western LNG, is currently seeking approval from the provincial regulator ...
2h
Will present initial Phase 1C dose escalation data for vilastobart (XTX101), a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab, in a late-breaker poster presentation at the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback